FNY Investment Advisers’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,200
| Closed | -$11K | – | 1031 |
|
2024
Q4 | $11K | Buy |
+1,200
| New | +$11K | 0.01% | 471 |
|
2024
Q1 | – | Sell |
-8,250
| Closed | -$27K | – | 857 |
|
2023
Q4 | $27K | Buy |
8,250
+750
| +10% | +$2.46K | 0.03% | 240 |
|
2023
Q3 | $17K | Sell |
7,500
-4,000
| -35% | -$9.07K | 0.01% | 320 |
|
2023
Q2 | $20K | Buy |
11,500
+1,500
| +15% | +$2.61K | 0.03% | 241 |
|
2023
Q1 | $30K | Buy |
+10,000
| New | +$30K | 0.03% | 226 |
|